| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Yale University School of Medicine, Section of Plastic Surgery, New Haven Connecticut 06520
Address all correspondence and requests for reprints to: Thomas L. McCarthy, Ph.D., Section of Plastic Surgery, 333 Cedar Street, P.O. Box 208041, New Haven, Connecticut 06520-8041. E-mail: thomas.mccarthy{at}yale.edu
Insulin-like growth factor (IGF)-binding protein-5 (IGFBP-5) has
IGF-dependent and -independent actions. PGE2 rapidly
increases IGFBP-5 expression by osteoblasts through cAMP-dependent
processes. A minimal DNA sequence required for basal and
PGE2-stimulated IGFBP-5 promoter activity spans -69 to
-35 bp. This region adjoins a functional TATA box and contains E box,
CCAAT enhancer-binding protein (C/EBP), nuclear factor-1 (NF-1),
and activator protein-2 (AP-2) transcription factor related
binding motifs. In this study we compared minimal promoter sequences of
-74 to +120 bp, without or with mutations in each potential regulatory
element, by reporter gene expression and electrophoretic mobility shift
assays. Mutation of the E box-related element reduced basal promoter
activity by 50% and eliminated the 2-fold stimulatory effect of
PGE2. In contrast, mutations in the C/EBP- or NF-1-related
elements also reduced basal promoter activity without fully eliminating
the PGE2 effect. Overexpression of C/EBP
stimulated
basal IGFBP-5 promoter activity, and this effect was eliminated by
mutating the C/EBP-binding site. However, mutation of the AP-2-binding
site or overexpression of AP-2 did not correlate with basal or
PGE2-induced promoter activation. By electrophoretic
mobility shift assay, prominent gel shift complexes occurred with
osteoblast nuclear extracts and 32P-labeled probes spanning
the E box-, C/EBP-, and NF-1-related motifs. These gel shift complexes
were depleted by specific binding site mutations and were enhanced by
PGE2. Increased binding by extracts from
PGE2-treated cultures was blocked by cycloheximide
treatment. These results identify several elements as integral binding
sequences for both basal and PGE2-stimulated IGFBP-5
promoter activity. They further reveal that multiple sequences within
this cluster form a basic transcription unit where nuclear factors can
accumulate in a protein synthesis-dependent way and enhance IGFBP-5
expression by osteoblasts in response to PGE2.
This article has been cited by other articles:
![]() |
M. A Meester-Smoor, A. C Molijn, Y. Zhao, N. A Groen, C. A H Groffen, M. Boogaard, D. van Dalsum-Verbiest, G. C Grosveld, and E. C Zwarthoff The MN1 oncoprotein activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence J. Mol. Endocrinol., January 1, 2007; 38(1): 113 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Norquay, X. Yang, Y. Jin, K. A. Detillieux, and P. A. Cattini Hepatocyte Nuclear Factor-3{alpha} Binding at P Sequences of the Human Growth Hormone Locus Is Associated with Pituitary Repressor Function Mol. Endocrinol., March 1, 2006; 20(3): 598 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Erclik and J. Mitchell Activation of the insulin-like growth factor binding protein-5 promoter by parathyroid hormone in osteosarcoma cells requires activation of an activated protein-2 element J. Mol. Endocrinol., June 1, 2005; 34(3): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy Fos-related Antigen 2 Controls Protein Kinase A-induced CCAAT/Enhancer-binding Protein {beta} Expression in Osteoblasts J. Biol. Chem., October 8, 2004; 279(41): 42438 - 42444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wickenheisser, V. L. Nelson-DeGrave, P. G. Quinn, and J. M. McAllister Increased Cytochrome P450 17{alpha}-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1 Mol. Endocrinol., March 1, 2004; 18(3): 588 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Grimm, T. N. Seagroves, E. B. Kabotyanski, R. C. Hovey, B. K. Vonderhaar, J. P. Lydon, K. Miyoshi, L. Hennighausen, C. J. Ormandy, A. V. Lee, et al. Disruption of Steroid and Prolactin Receptor Patterning in the Mammary Gland Correlates with a Block in Lobuloalveolar Development Mol. Endocrinol., December 1, 2002; 16(12): 2675 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Erclik and J. Mitchell The role of protein kinase C-delta in PTH stimulation of IGF-binding protein-5 mRNA in UMR-106-01 cells Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E534 - E541. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, X. Ma, L.-C. C. Yeh, and M. L. Adamo Differential Regulation of IGF-Binding Protein Gene Expression by cAMP in Rat C6 Glioma Cells Endocrinology, September 1, 2001; 142(9): 3917 - 3925. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-C. C. Yeh and J. C. Lee Identification of an Osteogenic Protein-1 (Bone Morphogenetic Protein-7)-Responsive Element in the Promoter of the Rat Insulin-Like Growth Factor-Binding Protein-5 Gene Endocrinology, September 1, 2000; 141(9): 3278 - 3286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hutt, J. P. O'Rourke, and J. DeWille Signal Transducer and Activator of Transcription 3 Activates CCAAT Enhancer-binding Protein delta Gene Transcription in G0 Growth-arrested Mouse Mammary Epithelial Cells and in Involuting Mouse Mammary Gland J. Biol. Chem., September 8, 2000; 275(37): 29123 - 29131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |